A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Clinical trial NCT05828511 · RECRUITING
Trial details
- NCT number
- NCT05828511
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2035-11-02
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.